Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global ECG Sensor Patch Market – Breakthrough for Cardiac Patients
ECG sensor patch play a major role in advanced healthcare, as it aids in detection of early asymptomatic atrial fibrillation (AFib). The sensor monitor is based on various parameters for continuously monitoring of the heart rhythm in cardiac patients.
The global ECG sensor patch market size was valued at US$ 11.7 million in 2017, and is expected to exhibit a CAGR of 43.7% over the forecast period (2018–2026).
Figure 1. Global ECG Sensor Patch Market Value (US$ Mn), by Region, 2018
Source: Coherent Market Insights Analysis (2019)
Technological advancements in ECG sensor patch and new product launch is expected to propel the market growth
Market players are focused on technological advancement and product launch in the potential market, which is expected to drive the global ECG sensor patch market. For instance, in 2016, VitalConnect launched the VitalPatch biosensor at the 2016 HIMSS Conference. The lightweight, wireless patch continuously monitors and records single lead ECG, heart rate, variability, respiratory rate, and other parameters with clinical accuracy.
Increasing focus of researchers on monitoring various body parameters is expected to augment the market growth over the forecast period. For instance, in 2016, engineers at the University of California, San Diego developed the first flexible wearable device that records ECG heart signals and tracks levels of lactate, a biochemical that is a marker of physical effort, in real time.
Rising strategic acquisitions and collaborations by market players for expanding their offerings in the market is expected to bolster the market growth. For instance, in January 2019, Medtronic Plc. announced to acquire EPIX Therapeutics, Inc. The acquisition is expected to expand Medtronic’s cardiac ablation portfolio for treating patient with cardiac arrhythmia.
However, high cost of ECG sensor monitoring patch is expected to hinder the market growth. For instance, Welch Allyn subsidiary of Hill-Rom Holdings, Inc.’s., TAGecg Wearable ECG Sensor costs around US$ 966, which can cause cost burden to lower economic regions.
Figure 2. Global ECG Sensor Patch Market Share (%), by Product Type, (2018-2026)
Source: Coherent Market Insights Analysis (2019)
Increasing prevalence of Atrial Fibrillation in North America is expected to bolster the market growth
North America holds dominant position in the global ECG sensor patch market over the forecast period, owing to increasing prevalence of atrial fibrillation and other cardiac conditions. According to American Heart Association, in 2016, stroke was a leading cause of death in the U.S. with around 2.7 million people in the country living with atrial fibrillation and around 800,000 suffering from a stroke, annually. It was due to block or bursts in the blood vessel that supplies blood to the brain. Therefore, increasing prevalence of atrial fibrillation boosts growth of the global ECG sensor patch market.
Increasing product launches and product approval in the region is the major factor expected to propel the market growth. For instance, in 2017, Cardiac Insight launched Cardea Solo ECG sensor designed for diagnosing atrial fibrillation following cardiac ablation after receiving the U.S. Food and Drugs Administration (FDA) 510 (k) clearance.
Moreover, increasing number of research and development activities and clinical trials to demonstrate the benefits of early detection of cardiac diseases is expected to augment the market growth. For instance, in 2018, the Scripps Translational Science Institute (STSI) in California, U.S., through the study mSToPS (mHealth Screening to Prevent Strokes), stated that wearable ECG patch demonstrated threefold improvement in diagnosis rate of atrial fibrillation than in usual care.
Key Players
Major players operating in the global ECG sensor patch market include Medtronic Plc., Hill-Rome Holdings, Inc., iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., and Lief Therapeutics
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
